Meet with our product experts in one-on-one virtual sessions

Set Up a Meeting
快速连接

Generic Formulation Products

Generic Formulation Products

Generic Formulation Products

Finished Dosage Forms - Product List:

Download Brochure

Dr. Reddy’s Laboratories is a leading API supplier, with a presence in over 80 countries and a portfolio of 200+ ANDA filings and approved dossiers. Our offering goes beyond APIs and our global customers have access to high-quality dossiers and finished dosage forms.

Therapy Area Product Name Oral Inj Strength Dossier Status Connect
中枢神经系统 Vigabatrin USP 500 mg Filed
中枢神经系统 Colchicine 0.6 mg Filed
中枢神经系统 Dimethyl Fumarate 120 mg and 240 mg 正在开发中
中枢神经系统 Topiramate ER 25, 50, 100 and 200 mg Filed
中枢神经系统 Edaravone 60 mg/100 ml Filed
中枢神经系统 Carboprost USP Inj 250 mcg/ml PFS Filed
其他 Apremilast 10, 20 and 30 mg Filed
其他 Posaconazole 100 mg Filed
其他 Naproxen Sodium 275 mg and 550 mg Filed
其他 Mesalamine 250 and 500 mg 正在开发中
其他 Amphotericin B 50 mg 正在开发中
其他 Thiamine 200 mg/2 ml 25's Filed
心血管的 Eltrombopag 12.5, 25, 50 and 75 mg Filed
心血管的 Bempedoic acid Ezetimibe 180 mg/10 mg 正在开发中
心血管的 Bempedoic acid 120 mg and 240 mg 正在开发中
心血管的 Edoxaban 15 mg, 30 mg and 60 mg 正在开发中
心血管的 Tafamidis Meglumine 20 mg 正在开发中
抗糖尿病 Sitagliptin HCL 25, 50, 100 mg Filed
抗糖尿病 Sitagliptin Phosphate + Metformin 50 + 500, 50 + 1000 mg Filed
抗糖尿病 Sitagliptin Phosphate 25, 50 and 100 mg Filed
抗糖尿病 Sitagliptin HCL + Metformin 50 + 500, 50 + 850 正在开发中
肿瘤 Bendamustine RTD 45 mg/ml (4 ml) and 25 mg/ml (4 ml) Filed
肿瘤 Bortezomib 3.5 mg Filed
肿瘤 Fingolimod 0.5 mg Filed
肿瘤 Busulfan 6 mg/ml (10 ml) Filed
肿瘤 Liposomal Doxorubicin 2 mg/ml (10 ml and 25 ml) Filed
肿瘤 Pazopanib 200 and 400 mg 正在开发中
肿瘤 Olaparib 100 mg and 150 mg 正在开发中
Therapy Area Product Name Dosage Form EU Approval Status US Approval Status
肿瘤 Everolimus 2.5mg, 5mg & 10mg Approved NA
肿瘤 Bortezomib For Injection 3.5 mg/vial Injection Approved Approved
Products under patent(s) are offered only for R&D purposes U/S 107A of the Patent Act and not for commercial sale.

Meet with our product experts in one-on-one virtual sessions

Our experts will answer your questions, provide advice, and help you understand our product better

Set Up a Meeting
仿制药

免责声明

本目錄中的任何信息（包括對任何產品或服務的任何引用）均不構成銷售要約，或被解釋為代表銷售要約。受有效專利保護的產品不提供或供應用於商業用途。但是，只要存在此類監管豁免，就可以出於監管提交的目的提供此類產品的研究數量。買方應對各自市場的專利方案進行獨立評估，並承擔所有與專利相關的責任。在印度受有效專利保護的產品不可用於商業用途，但可用於第 107A 節。